- BridgeBio gets funding for drug launch; United buys into cell therapyElsewhere, Otsuka’s kidney drug hit the goal of a confirmatory trial and Vertex’s CRISPR sickle cell drug secured expanded approval.BioPharma Dive · 27d ago↗ source
- STAT+: The moment Anthropic convinced me it’s serious about scienceAI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.STAT · 27d ago↗ source
- BridgeBio adds $1B as it prepares three more drug launchesBridgeBio Pharma has reloaded with about $1 billion in a preferred equity deal to bolster its reserves ahead of three potential drug launches over the next year. The California biotech, which for y…Endpoints · 27d ago